Table 1b:
Number of cytokeratin antibody combinations per case in the studied cohort (n=140).
No. of CKs used per case | No and (%) of cases |
---|---|
1 | 6 (4)* |
2 | 10 (7) |
3 | 13 (9) |
4 | 36 (26) |
5 | 28 (20) |
6 | 18 (13) |
7 | 9 (7) |
8 | 10 (7) |
9 | 10 (7)** |
6 cases (out of 140) were tested for only one CK;
10 cases (out of 140) were tested for a total of 9 CKs;
In this study, 22 cases were negative with all the CKs they were tested for, whereas 43 cases were positive for all the CKs used in their investigation.